Biospecifics Technologies Corp (BSTC) Return on Investment ROI from the third quarter of 2020 to third quarter of 2019 and for the year 2020, average high and low, overall ranking from Sep 30 2020 to Sep 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Biospecifics Technologies Corp  (NASDAQ: BSTC)


Biospecifics Technologies's ROI from its third quarter of 2020 to the third quarter of 2019 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Biospecifics Technologies's ROI in the third quarter of 2020?
Biospecifics Technologies Corp achieved a return on average invested assets (ROI) of 13.33 % in its third quarter of 2020, which is below Biospecifics Technologies's average return on investment, which stands at 20.35%.

ROI fell compared to the second quarter of 2020, despite the net income growth of 4551.81% from the second quarter of 2020.

Within the Healthcare sector 62 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2020 quarter, so far to 409, from total ROI ranking in the second quarter of 2020 at 442.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Investment Change TTM 21.77 % 25.09 % 27.63 % 27.12 % 28.23 %
Y / Y Net Income Change TTM -25.51 % -17.35 % 56.95 % 117.96 % 362.02 %
Investment (TTM) in Millions 136 130 130 125 118
Return On Investment (TTM) 13.33 % 14.52 % 20.33 % 21.5 % 21.79 %
BSTC's Overall Ranking # 409 # 442 # 246 # 272 # 295
Seq. Investment Change TTM 3.61 % 4.06 % 6.08 % 6.46 % 6.43 %
Seq. Net Income Change TTM -4.86 % -25.7 % 0.34 % 5.02 % 5.57 %
Net Income (TTM) in Millions 17 18 25 24 23

BSTC Company Profile >> Back to BSTC Roi Comparisons >> See Annual BSTC Return On Investment



Return On Investment BSTC's Ranking
Within: No.
Industry # 27
Sector # 63
Overall # 409

Return On Investment Statistics
High Average Low
25.81 %
20.35 %
13.33 %
(Dec 31 2013)   (Sep 30 2020)







Financial Statements
Biospecifics Technologies's III. Quarter Investments $ 136 Millions BSTC's Balance sheet
Biospecifics Technologies's III. Quarter Income $ 5 Millions Quarterly BSTC's Income Statement
BSTC's Income by Division See BSTC's Income by Division


BSTC Annual Return On Investment (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Investments in Millions 125 98 73 63 45
Y / Y Investment Growth 28.33 % 33.8 % 16.18 % 39.7 % 47.66 %
Net Income in Millions 24 20 11 11 10
Y / Y Net Income Growth 22.02 % 77.02 % -0.39 % 18.24 % 107.01 %
Annual Return On Investment 19.54 % 20.55 % 15.53 % 18.12 % 21.4 %


Annual Roi Comment
In the fiscal year 2019 ROI deteriorated to 19.54 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BSTC's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BSTC's Competitors
Subscribers only: Roi for Biospecifics Technologies's Suppliers
Subscribers only: Return On Investment for BSTC's Customers

Other Ratios
BSTC's Roa BSTC's Inventory Turnover Ratio BSTC's Growth Rates BSTC's Dividend Statistics
BSTC's Profitability Ratios BSTC's Asset Turnover Ratio BSTC's Dividend Growth
BSTC's Roe BSTC's Valuation Ratios BSTC's Financial Strength Ratios BSTC's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2020, within Healthcare Sector ROI
Lifevantage Corp  34.93 %
Vertex Pharmaceuticals Inc  33.58 %
Coherus Oncology inc   33.38 %
Innoviva Inc   32.19 %
Reflect Scientific Inc  31.91 %
Zynex inc   29.55 %
Idexx Laboratories Inc  28.69 %
Lakeland Industries Inc   28.62 %
Mettler toledo International Inc   28.18 %
Ironwood Pharmaceuticals inc   27.46 %
Corcept Therapeutics Inc  25.27 %
Pro dex Inc   25.08 %
Chemed Corporation  25.02 %
Regeneron Pharmaceuticals Inc   24.81 %
Siga Technologies Inc  24.45 %
Biogen Inc   23.42 %
Seagen Inc   23.40 %
Hologic Inc  20.25 %
Horizon Therapeutics Public Limited Company  19.83 %
Biomarin Pharmaceutical Inc  19.53 %
Eli Lilly And Company  18.81 %
Abiomed Inc   18.40 %
Merck and Co Inc   17.58 %
Resmed Inc   17.18 %
Bionexus Gene Lab Corp   16.68 %
Masimo Corp  16.35 %
Voyager Therapeutics Inc   16.26 %
89bio Inc   16.04 %
Zoetis Inc   15.66 %
West Pharmaceutical Services Inc   15.48 %

Date modified: 2026-09-26T07:12:56+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.